• 1. Excimer emission and magnetoluminescence of radical-based zinc(ii) complexes doped in host crystals?
  Shojiro Kimura,Tetsuro Kusamoto Chem. Commun., 2020,56, 11195-11198
• 2. Fast synthesis of copper nanoclusters through the use of hydrogen peroxide additive and their application for the fluorescence detection of Hg2+ in water samples?
  Liao Xiaoqing,Li Ruiyi,Li Zaijun,Sun Xiulan,Wang Zhouping,Liu Junkang New J. Chem., 2015,39, 5240-5248
• 3. Emerging 2D hybrid nanomaterials: towards enhanced sensitive and selective conductometric gas sensors at room temperature
  Hanie Hashtroudi,Ian D. R. Mackinnon J. Mater. Chem. C, 2020,8, 13108-13126
• 4. Evolution of cellulose into flexible conductive green electronics: a smart strategy to fabricate sustainable electrodes for supercapacitors
  Tengfei Yu,Yuehan Wu,Wei Li,Bin Li RSC Adv., 2014,4, 34134-34143
• 5. Excellent electrochemical performance of LiFe0.4Mn0.6PO4 microspheres produced using a double carbon coating process?
  Yong Ping Huang,Tao Tao,Zheng Chen,Wei Han,Ying Wu,Chunjiang Kuang,Shaoxiong Zhou,Ying Chen J. Mater. Chem. A, 2014,2, 18831-18837

Carbamic acid, N-[(2-hydroxyphenyl)methyl]-, phenylmethyl ester (CAS No. 854893-81-5): A Comprehensive Overview

Carbamic acid, N-[(2-hydroxyphenyl)methyl]-, phenylmethyl ester, commonly referred to by its CAS number 854893-81-5, is a specialized organic compound that has garnered significant attention in the field of pharmaceutical chemistry and bioorganic synthesis. This compound belongs to the class of carbamates, which are widely recognized for their diverse biological activities and utility in medicinal chemistry. The structural features of this molecule, particularly the presence of both 2-hydroxyphenyl and phenylmethyl ester groups, contribute to its unique chemical properties and potential applications in drug development.

The synthesis of Carbamic acid, N-[(2-hydroxyphenyl)methyl]-, phenylmethyl ester involves a series of well-defined chemical transformations that highlight the importance of precision and control in organic synthesis. The reaction pathway typically begins with the formation of a carbamate intermediate, which is subsequently modified to introduce the desired functional groups. This process underscores the compound's significance as a building block in the synthesis of more complex molecules.

In recent years, Carbamic acid, N-[(2-hydroxyphenyl)methyl]-, phenylmethyl ester has been studied for its potential role in the development of novel therapeutic agents. The hydroxyl group on the aromatic ring and the ester functionality provide multiple sites for chemical modification, enabling the design of molecules with tailored biological activities. For instance, researchers have explored its derivatives as potential inhibitors of various enzymes and receptors involved in metabolic pathways and inflammatory responses.

One of the most compelling aspects of this compound is its versatility in medicinal chemistry. The combination of a hydroxyl-containing aromatic ring and an ester group makes it a valuable intermediate for constructing more complex pharmacophores. This has led to its incorporation into several drug discovery programs aimed at identifying new treatments for diseases such as cancer, diabetes, and neurodegenerative disorders. The ability to modify both functional groups allows chemists to fine-tune the properties of these derivatives, optimizing them for specific biological targets.

The pharmacological profile of Carbamic acid, N-[(2-hydroxyphenyl)methyl]-, phenylmethyl ester and its derivatives has been extensively investigated. Preliminary studies suggest that certain modifications can enhance binding affinity to biological targets while minimizing off-target effects. This is crucial for developing drugs with improved efficacy and safety profiles. Additionally, the compound's stability under various conditions makes it suitable for formulation into different pharmaceutical dosage forms.

The role of computational chemistry in understanding the behavior of Carbamic acid, N-[(2-hydroxyphenyl)methyl]-, phenylmethyl ester cannot be overstated. Advanced computational methods have been employed to predict molecular interactions and optimize synthetic routes. These techniques have provided valuable insights into how structural modifications can influence biological activity, guiding the design of more effective drug candidates.

In conclusion, Carbamic acid, N-[(2-hydroxyphenyl)methyl]-, phenylmethyl ester (CAS No. 854893-81-5) represents a significant advancement in pharmaceutical chemistry. Its unique structural features and versatile reactivity make it a valuable tool for drug discovery and development. As research continues to uncover new applications for this compound and its derivatives, its importance in medicinal chemistry is likely to grow even further.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)